Key result
Visceral Adiposity Index was the sole determinant of adiponectin levels (R2 = 0.07, beta -0.25) and, along with age, predicted the presence of impaired fasting glucose or diabetes.
Why the study?
Is the Visceral Adiposity Index associated with adiponectin levels and glycaemic disturbances in adult subjects?
Population
308 adult Saudi subjects
Design
Cohort
Authors
Loading...
VAI associates with adiponectin and glycaemic risk in cohort data; hypothesis-generating and requires prospective validation before clinical use.
Cohort (n=308)
Is the Visceral Adiposity Index associated with adiponectin levels and glycaemic disturbances in adult subjects?
Effect estimate: beta -0.25
The Visceral Adiposity Index is a simple clinical tool that correlates with adiponectin levels and the risk of impaired glucose metabolism.
Al‐Daghri et al. (2012) reported a cohort. Visceral Adiposity Index (VAI) was evaluated on Adiponectin levels (beta -0.25). Visceral Adiposity Index was the sole determinant of adiponectin levels (R2 = 0.07, beta -0.25) and, along with age, predicted the presence of impaired fasting glucose or diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: